Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.

Novel scoring tool predicts 1-year mortality in elderly cancer patients

01 May 2020

MetaGENUA, a novel six-variable scoring scheme, can reliably predict mortality in elderly cancer patients, a recent study has shown.

Researchers conducted a single-centre, prospective analysis of 162 elderly cancer patients (mean age, 78±5.5 years; 57 percent female) who underwent a comprehensive geriatric assessment (CGA) before receiving treatment. The outcome of interest was 1-year mortality.

More than half of the participants had impairments in at least three clinical domains of the CGA and were identified as frail. This was mostly driven by multimorbidity, a heightened risk of malnutrition and an initial decline in instrumental activities of daily living (IADL).

Twenty-two patients died within the first year of surgery, yielding an overall 1-year mortality rate of 13.5 percent. Seventy-seven percent of the deaths were related to cancer.

Six variables made up the final prediction model: age, IADL, cancer stage, malnutrition risk, geriatric depression scale scores and cumulative illness rating scale scores. Taken together, the model had an overall accuracy of 0.65 in the training cohort. There was also relative ease of use, with an estimated mean time of MetaGENUA score generation of 20 minutes.

Upon validation, the model yielded a sensitivity of 0.59 and a specificity of 0.86. The resulting area under the receiver operator characteristic curve was 0.72 (95 percent confidence interval, 0.55–0.87).

“We anticipate that the routine use of MetaGENUA will allow a more rational administration of cancer treatments and translate into improved clinical outcomes both in terms of oncological and geriatric endpoints,” the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.